ContraFect Secures $20,000,000 New Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9569dfe0-4bd9-4189-9e60-e7ca9b251233
Date
6/25/2015
Company Name
ContraFect
Mailing Address
28 Wells Avenue 3rd Floor Yonkers, NY 10701 USA
Company Description
ContraFect is a biotechnology company pioneering the use of monoclonal antibodies to treat life-threatening infectious diseases.
Website
http://www.contrafect.com
Transaction Type
Venture Equity
Transaction Amount
$20,000,000
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
M&A Terms
Venture Investor